336 related articles for article (PubMed ID: 15967421)
1. Role of SHP-1, Kv.1.2, and cGMP in nitric oxide-induced ERK1/2 MAP kinase dephosphorylation in rat vascular smooth muscle cells.
Palen DI; Belmadani S; Lucchesi PA; Matrougui K
Cardiovasc Res; 2005 Nov; 68(2):268-77. PubMed ID: 15967421
[TBL] [Abstract][Full Text] [Related]
2. Rapid and delayed p42/p44 mitogen-activated protein kinase activation by nitric oxide: the role of cyclic GMP and tyrosine phosphatase inhibition.
Callsen D; Pfeilschifter J; Brüne B
J Immunol; 1998 Nov; 161(9):4852-8. PubMed ID: 9794418
[TBL] [Abstract][Full Text] [Related]
3. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells.
Redmond EM; Cahill PA; Hodges R; Zhang S; Sitzmann JV
J Cell Physiol; 1996 Mar; 166(3):469-79. PubMed ID: 8600150
[TBL] [Abstract][Full Text] [Related]
4. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide modulates Gi-protein expression and adenylyl cyclase signaling in vascular smooth muscle cells.
Bassil M; Anand-Srivastava MB
Free Radic Biol Med; 2006 Oct; 41(7):1162-73. PubMed ID: 16962941
[TBL] [Abstract][Full Text] [Related]
6. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
Persson AA; Gunnarsson P; Lindström E; Grenegård M
Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
[TBL] [Abstract][Full Text] [Related]
7. Treatment with insulin uncovers the motogenic capacity of nitric oxide in aortic smooth muscle cells: dependence on Gab1 and Gab1-SHP2 association.
Dixit M; Zhuang D; Ceacareanu B; Hassid A
Circ Res; 2003 Nov; 93(10):e113-23. PubMed ID: 14551245
[TBL] [Abstract][Full Text] [Related]
8. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation.
Li B; Yang L; Shen J; Wang C; Jiang Z
Anesth Analg; 2007 Oct; 105(4):1034-41, table of contents. PubMed ID: 17898384
[TBL] [Abstract][Full Text] [Related]
9. Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance.
Doronzo G; Russo I; Mattiello L; Anfossi G; Bosia A; Trovati M
Eur J Clin Invest; 2004 Oct; 34(10):664-73. PubMed ID: 15473891
[TBL] [Abstract][Full Text] [Related]
10. Expression and functional role of the RhoA/Rho-kinase pathway in rat coeliac artery.
Teixeira CE; Jin L; Ying Z; Palmer T; Priviero FB; Webb RC
Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):817-24. PubMed ID: 16173942
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the mechanisms underlying the relaxation induced by two nitric oxide donors: sodium nitroprusside and a new ruthenium complex.
Bonaventura D; de Lima RG; Vercesi JA; da Silva RS; Bendhack LM
Vascul Pharmacol; 2007 Mar; 46(3):215-22. PubMed ID: 17127100
[TBL] [Abstract][Full Text] [Related]
12. Src tyrosine kinase inhibitor PP2 suppresses ERK1/2 activation and epidermal growth factor receptor transactivation by X-irradiation.
Li Z; Hosoi Y; Cai K; Tanno Y; Matsumoto Y; Enomoto A; Morita A; Nakagawa K; Miyagawa K
Biochem Biophys Res Commun; 2006 Mar; 341(2):363-8. PubMed ID: 16414009
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
[TBL] [Abstract][Full Text] [Related]
14. Differential sensitivity among nitric oxide donors toward ODQ-mediated inhibition of vascular relaxation.
Tseng CM; Tabrizi-Fard MA; Fung HL
J Pharmacol Exp Ther; 2000 Feb; 292(2):737-42. PubMed ID: 10640313
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide attenuates endothelin-1-induced activation of ERK1/2, PKB, and Pyk2 in vascular smooth muscle cells by a cGMP-dependent pathway.
Bouallegue A; Daou GB; Srivastava AK
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2072-9. PubMed ID: 17644565
[TBL] [Abstract][Full Text] [Related]
17. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts.
Huang JS; Chuang LY; Guh JY; Chen CJ; Yang YL; Chiang TA; Hung MY; Liao TN
J Am Soc Nephrol; 2005 Aug; 16(8):2318-29. PubMed ID: 15958724
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors (sst2) regulate cGMP production in rat retina.
Mastrodimou N; Kiagiadaki F; Hodjarova M; Karagianni E; Thermos K
Regul Pept; 2006 Jan; 133(1-3):41-6. PubMed ID: 16280179
[TBL] [Abstract][Full Text] [Related]
19. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite.
Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R
J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111
[TBL] [Abstract][Full Text] [Related]
20. Evidence that spontaneous contractile activity in the rat myometrium is not inhibited by NO-mediated increases in tissue levels of cyclic GMP.
Hennan JK; Diamond J
Br J Pharmacol; 1998 Mar; 123(5):959-67. PubMed ID: 9535026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]